DeutschNewstral
Article
bizjournals.com on 2020-08-06 16:36
Longtime Alnylam exec Barry Greene leaving biotech
Related news
- Top former Alnylam exec Barry Greene named CEO of Sage Therapeuticsbizjournals.com
- Pittsburgh biotech names Alnylam exec as new chief commercial officerbizjournals.com
- How biotech Alnylam plans to make a profit, and what stands in its waybizjournals.com
- Watertown biotech Lyndra snags longtime Vertex exec as CEObizjournals.com
- Why a longtime biotech exec shunned retirement for startup 'breakthrough'bizjournals.com
- Longtime biotech exec walks away from board to concentrate on startupbizjournals.com
- Why 'Kimtirement' is a real thing with this longtime biotech execbizjournals.com
- BThe Interview: Biotech Leader and Alnylam CEO Yvonne Greenstreetbostonmagazine.com
- Cancer biotech exec blends biotech, philosophy, entrepreneurshipbizjournals.com
- Longtime Macy's exec resignsbizjournals.com
- Alnylam plans Cambridge expansion after $2B investmentbizjournals.com
- Alnylam to move HQ to former Vertex site in big 2018 biotech shufflebizjournals.com
- Volunteer day at Alnylam Pharmaceuticals helps raise company’s profilebizjournals.com
- Alnylam plans to divvy new hires between Cambridge and Philadelphiabizjournals.com
- In a first, Alnylam reports success silencing genes in childrenbizjournals.com
Longtime Newsday exec. secretary diesNewsday- Longtime Hoove exec to retirebizjournals.com
Alnylam Touts Positive Data On Second Drug, Plans FDA MeetingForbes- The Petri Dish: Amylyx, Alnylam net drug approvalsbizjournals.com
- Longtime Birmingham exec to retirebizjournals.com